Co-diagnostics(us:CODX)
0.7154
-2.00%
Updated on 2024-12-23
Open:0.7280
Close:0.7154
High:0.7500
Low:0.7020
Pre Close:0.7300
Volume:168219.00
Amount:121552.69
Turnover:0.53%
Shares:31.93M
MarketCap:22.84M
About Co-diagnostics Company
Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.
Company Name: Co-diagnostics
Company Address: 2401 South Foothill Drive,Suite D
Employees: 155
Fiscar Year: 12-31
IPO Date: 2017-07-12
Website: http://www.codiagnostics.com
CIK: 1692415
View all SEC Filings
About
Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.
Address:2401 South Foothill Drive,Suite D
Website:http://www.codiagnostics.com
Market Movers